This video explores the reasons behind India's decision to join PIC/S and its potential impact on the Indian pharmaceutical market. The UAE and other advanced economies often reference prices in developed markets, which pose barriers for affordable Indian drugs, despite their superior quality. Talks are underway to address pricing norms and facilitate Indian generic drug and vaccine exports. The absence of India and China from PIC/S has skewed the price mechanism towards higher prices, hindering Indian exporters of affordable medicines
9 Jun 2023Indian pharma in 2023: Industry experts give big thumbs up to the sector. Here's what they are saying. According to a recent EY FICCI report, the Indian pharmaceutical market is estimated to touch $130 billion in value by the end of 2030.
7 May 2023The government had exempted innovative medicines made by foreign firms from price caps for five years
2 min read5 Jan 2019NGOs, however, have criticised the decision saying it shrinks the space to make medicines more affordable
1 min read4 Jan 2019The spike in deal activity could be attributed to Aurobindo Pharma's agreement to buy units of Sandoz for $1 billion
3 min read25 Sep 2018New HIV therapy hits safety, efficacy targets, says another recent study published in the ‘Lancet HIV’
2 min read11 Oct 2017The USFDA move to hike the ANDA processing fee will hurt the Indian pharma industry which is heavily dependent on the US market for exports
2 min read29 Aug 2017‘Indian pharma industry may grow around 13% in 2009’
1 min read19 Mar 2009Fresh stay on order in South as DCGI files caveats in North
2 min read5 Dec 2007The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared
TCS News: Get Tata Consultancy Services LIVE NSE/BSE News on Stock/Share Price along with Stock Charts, Returns, Research Reports on mint.